Aemetis Inc. (NASDAQ:AMTX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Wednesday. The firm currently has a $2.00 price target on the stock. Zacks Investment Research’s target price would indicate a potential upside of 9.89% from the stock’s previous close.
According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “
Separately, FBR & Co reissued a “hold” rating and set a $2.50 price objective on shares of Aemetis in a research note on Tuesday, August 16th.
Aemetis (NASDAQ:AMTX) opened at 1.82 on Wednesday. The firm’s market cap is $36.14 million. Aemetis has a 52 week low of $1.01 and a 52 week high of $3.05. The stock’s 50 day moving average is $1.63 and its 200 day moving average is $1.88.
Aemetis (NASDAQ:AMTX) last released its quarterly earnings data on Monday, November 14th. The company reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.06. Equities research analysts expect that Aemetis will post ($1.04) EPS for the current year.
A hedge fund recently raised its stake in Aemetis stock. Geneva Advisors LLC boosted its stake in Aemetis Inc. (NASDAQ:AMTX) by 4.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,453,131 shares of the company’s stock after buying an additional 68,460 shares during the period. Geneva Advisors LLC owned 7.32% of Aemetis worth $1,569,000 at the end of the most recent quarter. 18.57% of the stock is owned by institutional investors and hedge funds.
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.